Literature DB >> 7539834

Screening a monoclonal antibody with a fusion-phage display library shows a discontinuity in a linear epitope within PreS1 of hepatitis B virus.

V Germaschewski1, K Murray.   

Abstract

The epitope recognized by the monoclonal antibody MA18/7, specific for the PreS1-domain of the hepatitis B virus surface antigen, has been defined precisely by means of a library of fusion-phage carrying random hexapeptides on the tip of filamentous phage fd particles. Phage, isolated after only one round of affinity selection, displayed hexapeptides showing strong conservation of the PreS1 primary sequence in the region 19-23 with three noncontiguous residues, DP (20 and 21) and F (23) appearing in phage that bound the antibody. The importance of these core residues was supported by comparing the antibody binding of individual phage in solution, which provided relative dissociation constants for these interactions. Replacement of F (23) by Y was the only substitution observed in the three core residues, and resulted in somewhat weaker binding. Synthetic tetra- and hexapeptides containing these key residues inhibited the reaction between the phage and the antibody.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539834     DOI: 10.1002/jmv.1890450311

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

Review 1.  Applications of human hepatitis B virus preS domain in bio- and nanotechnology.

Authors:  Riki Toita; Takahito Kawano; Jeong-Hun Kang; Masaharu Murata
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

2.  Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications.

Authors:  Lourena E Costa; Mayara I S Lima; Miguel A Chávez-Fumagalli; Daniel Menezes-Souza; Vivian T Martins; Mariana C Duarte; Paula S Lage; Eliane G P Lopes; Daniela P Lage; Tatiana G Ribeiro; Pedro H R Andrade; Danielle F de Magalhães-Soares; Manuel Soto; Carlos A P Tavares; Luiz R Goulart; Eduardo A F Coelho
Journal:  Clin Vaccine Immunol       Date:  2013-11-20

3.  Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus.

Authors:  Dieter Glebe; Mehriar Aliakbari; Peter Krass; Eva V Knoop; Klaus P Valerius; Wolfram H Gerlich
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 4.  Phage display creates innovative applications to combat hepatitis B virus.

Authors:  Wen Siang Tan; Kok Lian Ho
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

5.  Direct measurement via phage titre of the dissociation constants in solution of fusion phage-substrate complexes.

Authors:  M R Dyson; V Germaschewski; K Murray
Journal:  Nucleic Acids Res       Date:  1995-05-11       Impact factor: 16.971

6.  Structures of hepatitis B virus cores presenting a model epitope and their complexes with antibodies.

Authors:  A M Roseman; O Borschukova; J A Berriman; S A Wynne; P Pumpens; R A Crowther
Journal:  J Mol Biol       Date:  2012-06-28       Impact factor: 5.469

7.  Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis.

Authors:  Lourena Emanuele Costa; Luiz Ricardo Goulart; Nathália Cristina de Jesus Pereira; Mayara Ingrid Sousa Lima; Mariana Costa Duarte; Vivian Tamietti Martins; Paula Sousa Lage; Daniel Menezes-Souza; Tatiana Gomes Ribeiro; Maria Norma Melo; Ana Paula Fernandes; Manuel Soto; Carlos Alberto Pereira Tavares; Miguel Angel Chávez-Fumagalli; Eduardo Antonio Ferraz Coelho
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

8.  Selection of binding targets in parasites using phage-display and aptamer libraries in vivo and in vitro.

Authors:  R R Tonelli; W Colli; M J M Alves
Journal:  Front Immunol       Date:  2013-01-09       Impact factor: 7.561

9.  Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis.

Authors:  Luciana M Bastos; Arlindo G Macêdo; Murilo V Silva; Fernanda M Santiago; Eliezer L P Ramos; Fabiana A A Santos; Carlos P Pirovani; Luiz R Goulart; Tiago W P Mineo; José R Mineo
Journal:  Front Cell Infect Microbiol       Date:  2016-06-01       Impact factor: 5.293

10.  The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.

Authors:  Andris Dishlers; Dace Skrastina; Regina Renhofa; Ivars Petrovskis; Velta Ose; Ilva Lieknina; Juris Jansons; Paul Pumpens; Irina Sominskaya
Journal:  Mol Biotechnol       Date:  2015-12       Impact factor: 2.695

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.